Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Speaking valve to help breathing, swallowing, and voice for people with a tracheostomy

Official title: Speaking Valve Influence on Breathing, Swallowing and Vocal Functions in Patients With Tracheostomy.

Run by Loewenstein Hospital · NCT05482022 · Data updated 2026-11-12

This project will try a speaking valve during respiratory therapy to see if it helps breathing, secretion control, swallowing, and vocal function in people with a tracheostomy who are not on mechanical ventilation and have disorders of consciousness.

More Tracheostomy trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment30 (estimated)
SponsorLoewenstein Hospital
Academic / other
Locations1 site (Raanana)
StatusRecruiting
StartedAugust 1, 2022
Main results expectedMarch 27, 2025
Study endsJanuary 15, 2026
Registry record updatedAugust 14, 2025
Trial IDNCT05482022 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with tracheostomy after traumatic or non‑traumatic brain injury who are in an unresponsive wakefulness syndrome or minimally conscious state, not mechanically ventilated, with good vocal cord mobility and a Hebrew‑speaking legal guardian are ideal candidates.

Probably not a fit

Patients with airway stenosis or inflammation, oxygen saturation under 90%, poor vocal cord mobility, or who require mechanical ventilation are unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study will apply a Shiley™ phonate speaking valve during respiratory physical therapy sessions and compare outcomes against a control condition in patients with tracheostomy after brain injury. Eligible participants are in unresponsive wakefulness syndrome or a minimally conscious state, are not mechanically ventilated, and pass a fiber-optic exam showing good vocal cord mobility and no airway granulation (MarianJoy score 1-3). Key exclusions include airway stenosis or inflammation and oxygen saturation below 90%. The trial is single-center at Loewenstein Rehabilitation Hospital and will monitor breathing, secretion management, swallowing, and vocal function during therapy sessions.

Why it matters

Potential benefit: If successful, using a speaking valve during therapy could improve breathing, secretion clearance, swallowing safety, and vocal function, potentially reducing respiratory complications and easing day-to-day care for people with tracheostomy.

How similar studies have gone: Speaking valves have shown benefit for subglottic pressure, secretion management, and swallowing in some prior studies of tracheostomized patients, but evidence specifically in those with disorders of consciousness is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* brain injury (traumatic/non-traumatic).
* tracheostomy.
* unresponsive wakefulness syndrome or minimally conscious state.
* fiber optic examination as follows: good mobilization of the vocal cords. No airway granulation, MarianJoy scale score: 1-3.
* the legal guardian speaks Hebrew.

Exclusion Criteria:

* airway stenosis / inflammation.
* oxygen saturation \<90%.

Where it's running

  • Loewenstein Rehabilitation Hospital
    Raanana, Israel
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.